Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Assets (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Assets for 15 consecutive years, with $267.0 million as the latest value for Q4 2025.

  • Quarterly Assets fell 21.73% to $267.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $267.0 million through Dec 2025, down 21.73% year-over-year, with the annual reading at $267.0 million for FY2025, 21.73% down from the prior year.
  • Assets hit $267.0 million in Q4 2025 for Perspective Therapeutics, down from $294.8 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $391.2 million in Q3 2024 to a low of $58.1 million in Q4 2022.
  • Historically, Assets has averaged $179.2 million across 5 years, with a median of $115.3 million in 2023.
  • Biggest five-year swings in Assets: soared 756.2% in 2021 and later dropped 24.63% in 2025.
  • Year by year, Assets stood at $67.3 million in 2021, then decreased by 13.62% to $58.1 million in 2022, then surged by 68.51% to $97.9 million in 2023, then skyrocketed by 248.45% to $341.1 million in 2024, then decreased by 21.73% to $267.0 million in 2025.
  • Business Quant data shows Assets for CATX at $267.0 million in Q4 2025, $294.8 million in Q3 2025, and $310.7 million in Q2 2025.